WH urges FDA to reconsider HCQ for COVID-19 treatment
Washington: The White House has urged the US Food and Drug Administration (FDA) to reinstate its emergency use authorization (EUA) for the anti-malaria drug, hydroxychloroquine (HCQ), for COVID-19 treatment. Weeks ago, …
WH urges FDA to reconsider HCQ for COVID-19 treatment Read More